Ceftriaxone
8 NDCs across 5 manufacturers|8 Generic,0 Brand
Ceftriaxone is used to treat acinetobacter infections, bacteroidaceae infections, infectious bone diseases, chancroid, clostridium infections and enteritis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
Ceftriaxone is available as 8 NDCs from 5 manufacturers (8 generic, 0 brand), with NADAC prices from $1.44 to $25.21 per EA — the most expensive product costs about 17× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
8
8G / 0B
Manufacturers
5
competing in market
Price Spread
$1.44 – $25.21
per EA
7d Activity
avg +1.2% WoW · of 8 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
5 manufacturers producing CEFTRIAXONE(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CEFTRIAXONE 10 GM VIAL | $25.2133 per EA | — |
CEFTRIAXONE 500 MG VIAL | $3.3386 per EA | — |
CEFTRIAXONE 1 GM VIAL | $1.4427 per EA | +1.23% |
CEFTRIAXONE 1 GM VIAL | $1.4427 per EA | +1.23% |
CEFTRIAXONE 1 GM VIAL | $1.4427 per EA | +1.23% |
CEFTRIAXONE 1 GM VIAL | $1.4427 per EA | +1.23% |
CEFTRIAXONE 1 GM VIAL | $1.4427 per EA | +1.23% |
CEFTRIAXONE 1 GM VIAL | $1.4427 per EA | +1.23% |
Frequently Asked Questions
What is Ceftriaxone used to treat?
Ceftriaxone is used to treat acinetobacter infections, bacteroidaceae infections, infectious bone diseases, chancroid, clostridium infections and enteritis, per the National Library of Medicine's MED-RT classification.
How many Ceftriaxone products are on the market?
The Ceftriaxone drug market contains 8 NDCs from 5 manufacturers — 8 generic and 0 brand products.
What is the price range for Ceftriaxone?
NADAC reference prices for Ceftriaxone range from $1.4427 to $25.2133 per EA — the most expensive product costs about 17× the cheapest.
Which manufacturers make Ceftriaxone?
5 manufacturers list Ceftriaxone in NADAC. Ranked by number of NDCs, the largest are WG Critical Care, LLC (4), Hikma Pharmaceuticals USA Inc. (1), Civica, Inc. (1), Fresenius Kabi USA, LLC (1), Sagent Pharmaceuticals (1).
How has the price of Ceftriaxone changed recently?
Over the past 7 days, 6 Ceftriaxone NDCs rose and 0 fell, with a market-wide average change of +1.2%.